UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant

Nature communications, 2016-05, Vol.7 (1), p.11579-11579, Article 11579

2016

Volltextzugriff (PDF)

Comprehensive analysis of HE4 expression in normal and malignant human tissues

Modern pathology, 2006-06, Vol.19 (6), p.847-853

2006

Volltextzugriff (PDF)

ERK inhibition overcomes acquired resistance to MEK inhibitors

Molecular cancer therapeutics, 2012-05, Vol.11 (5), p.1143-1154

2012

Volltextzugriff (PDF)

High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing

Clinical cancer research, 2014-04, Vol.20 (8), p.2080-2091

2014

Volltextzugriff (PDF)

High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck

PloS one, 2013-02, Vol.8 (2), p.e56765-e56765

2013

Volltextzugriff (PDF)

Large-Scale Analysis of the Human and Mouse Transcriptomes

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (7), p.4465-4470

2002

Volltextzugriff (PDF)

DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non―Small Cell Lung Cancer

Clinical cancer research, 2012-04, Vol.18 (8), p.2360-2373

2012

Volltextzugriff (PDF)

A Small Interfering RNA Screen for Modulators of Tumor Cell Motility Identifies MAP4K4 as a Promigratory Kinase

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (10), p.3775-3780

2006

Volltextzugriff (PDF)

Targeted biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers

PloS one, 2014-02, Vol.9 (2), p.e88401-e88401

2014

Volltextzugriff (PDF)

Profiling Cancer Gene Mutations in Clinical Formalin‐Fixed, Paraffin‐Embedded Colorectal Tumor Specimens Using Targeted Next‐Generation Sequencing

The oncologist (Dayton, Ohio), 2014-04, Vol.19 (4), p.336-343

2014

Volltextzugriff (PDF)

Large-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum

Proceedings of the National Academy of Sciences - PNAS, 2003-03, Vol.100 (6), p.3410-3415

2003

Volltextzugriff (PDF)

Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays

Modern pathology, 2003-09, Vol.16 (9), p.913-919

2003

Volltextzugriff (PDF)

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers

PloS one, 2016-11, Vol.11 (11), p.e0165856-e0165856

2016

Volltextzugriff (PDF)

Cdc6 and Cyclin E2 Are PTEN-Regulated Genes Associated with Human Prostate Cancer Metastasis

Neoplasia (New York, N.Y.), 2009-01, Vol.11 (1), p.66-76

2009

Volltextzugriff (PDF)

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non―Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

Clinical cancer research, 2012-04, Vol.18 (8), p.2391-2401

2012

Volltextzugriff (PDF)

Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin

Oncogene, 2004-08, Vol.23 (39), p.6621-6629

2004

Volltextzugriff (PDF)

Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis

Clinical cancer research, 2006-01, Vol.12 (1), p.89-96

2006

Volltextzugriff (PDF)

Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models

Clinical cancer research, 2012-12, Vol.18 (24), p.6771-6783

2012

Volltextzugriff (PDF)

Discovery and development of DNA methylation-based biomarkers for lung cancer

Epigenomics, 2014-02, Vol.6 (1), p.59-72

2014

Volltextzugriff (PDF)

Profiling the evolution of human metastatic bladder cancer

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (21), p.7813-7821

2004

Volltextzugriff (PDF)

Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5), p.1193-1203

2016

Volltextzugriff (PDF)

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma

Clinical cancer research, 2007-01, Vol.13 (2), p.458-466

2007

Volltextzugriff (PDF)

c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function: A Mechanism for Oncogene-Induced Genetic Instability

Molecular cell, 2002-05, Vol.9 (5), p.1031-1044

2002

Volltextzugriff (PDF)

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer

Cancer research (Chicago, Ill.), 2001-08, Vol.61 (16), p.5974-5978

2001

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(83)
Bücher
(1)

Sprache

Englisch
(84)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(62)
Life Sciences & Biomedicine
(53)
Oncology
(36)
Biological And Medical Sciences
(33)
Tumors
(33)
Female
(31)
Medical Sciences
(29)
Gene Expression Profiling
(17)
Gene Expression Regulation, Neoplastic
(16)
Gene Expression
(15)
Cancer
(14)
Male
(14)
Oligonucleotide Array Sequence Analysis
(13)
Cell Line, Tumor
(11)
Genes
(11)
Genetics & Heredity
(11)
Immunohistochemistry
(11)
Multidisciplinary Sciences
(11)
Neoplasms - Genetics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant

Comprehensive analysis of HE4 expression in normal and malignant human tissues

ERK inhibition overcomes acquired resistance to MEK inhibitors

High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing

High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck

Large-Scale Analysis of the Human and Mouse Transcriptomes

DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non―Small Cell Lung Cancer

A Small Interfering RNA Screen for Modulators of Tumor Cell Motility Identifies MAP4K4 as a Promigratory Kinase

Targeted biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers

Profiling Cancer Gene Mutations in Clinical Formalin‐Fixed, Paraffin‐Embedded Colorectal Tumor Specimens Using Targeted Next‐Generation Sequencing

Large-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum

Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers

Cdc6 and Cyclin E2 Are PTEN-Regulated Genes Associated with Human Prostate Cancer Metastasis

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non―Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin

Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis

Correction: High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck

Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models

Discovery and development of DNA methylation-based biomarkers for lung cancer

Profiling the evolution of human metastatic bladder cancer

Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma

c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function: A Mechanism for Oncogene-Induced Genetic Instability

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer

Suchergebnisse filtern